Global Veterinary Molecular Diagnostic Market (2018-2025)-GMI Research

1. Global Veterinary Molecular Diagnostic Market (2018-2025)-GMI Research Posted by Sarah Nash December 17, 2018 in Healthcare Global Veterinary Molecular Diagnostic Market By Product Type (Instruments and Consumables {Reagents, Kits and Others), By Technology (Polymerase Chain Reaction, INAAT, Microarrays and DNA Sequencing), By Animal Type (Companion Animals {Dogs, Horses and Cats} and Livestock Animals {Pigs, Cattles, Poultry and Others}), By End-Users (Veterinary Hospitals, Clinical Laboratories and Research Institutes) and by Geography – Opportunities & Forecast, 2018-2025 The veterinary molecular diagnostic utilizes various type of technique such as nucleic acid diagnostic techniques, biochips, DNA Sequencing, etc to detect the presence of nucleic acids (DNA/RNA) from pathogenic organisms in clinical samples of animals. A wide variety of tests are available for bacteria, fungi, and

2. viruses from many animal species, including pathogens of cattle, cats, dogs, horses, and others. Nucleic acid diagnostic techniques such as polymerase chain reaction (PCR) is widely adopted molecular diagnostic tools used for animals to rapidly screen large numbers of samples during disease outbreaks. For instance, European Food Safety Authority stated that approximately 320,000 cases of foodborne and zoonotic diseases are reported each year across the globe. Request Sample Pages : https://tinyurl.com/ybrbh62n Rising prevalence of zoonotic disease, increasing diagnosis rate due to the rise in spending on animal health care are the major driving factors which are expected to boost the growth of veterinary molecular diagnostic market during the forecast period. In addition, the introduction of innovative veterinary diagnostic, and rise in foodborne disease is expected to be one of the crucial reasons for the growth of veterinary molecular diagnostic market. Moreover, increasing penetration of molecular diagnostics for veterinary due to the presence of strong distribution channel, rising urbanization, and with high disposable incomes pet owners frequently visit the veterinary facilities are some of the factors boosting the growth of this market. However, the dearth of the skilled veterinary practitioner and low awareness regarding veterinary molecular diagnostic in developed and developing countries acts as a restraining factor for the market. Various notable players operating in the market, Thermo Fisher Scientific Inc., QIAGEN N.V., IDEXX Laboratories Inc., VCA Inc., Biomedica Medizinprodukte GmbH & Co. KG, HealthGene Corporation, Bioneer, ABAXIS Inc, Neogen Corporation among others. Most of the company are focusing on strategic collaboration with the animal health care service provider to increase the penetration of veterinary molecular diagnostic in emerging economies such as China, India, Brazil, etc.

3. The global veterinary molecular diagnostic market has been segmented based on product type, technology, animal, end-use, and key geographies. Based on product type, the market comprises of instruments and consumables. The research report “global veterinary molecular diagnostic market” provides in- depth analysis of global veterinary molecular diagnostic market based on product type, technology, animal type, end-user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global veterinary molecular diagnostic market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market. Key questions answered in this research report: 1- At what pace is veterinary molecular diagnostic market growing? What will be growth trend in future? 2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future? 3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the veterinary molecular diagnostic market? 4- What are the various application areas and how they are poised to grow? Market Segmentation By Product Type • Instruments • Consumables o Reagents o Kits o Others

4. By Technology • PCR • INAAT • Microarrays • DNA Sequencing By Animal type • Companion Animals o Dogs o Horses o Cats • Livestock Animals o Pigs o Cattles o Poultry o Others By End-Users • Veterinary Hospitals • Clinical Laboratories • Research Institutes By Geography • North America As a part of customization o By Product Type o By Technology o By Animal Type o By End users o US o Canada o Mexico

5. • Europe As a part of customization o By Product Type o By Technology o By Animal Type o By End users o UK o Germany o Spain o Rest of Europe • Asia-Pacific As a part of customization o By Product Type o By Technology o By Animal Type o By End users o China o Australia o India o Rest of APAC • ROW As a part of customization o By Product Type o By Technology o By Animal Type o By End users o Brazil o South Africa o GCC countries

6. o Rest of world (remaining countries of the LAMEA region) Leading market players • Thermo Fisher Scientific Inc. • QIAGEN N.V. • IDEXX Laboratories Inc. • VCA Inc. • Biomedica Medizinprodukte GmbH & Co. KG • HealthGene Corporation • Bioneer • ABAXIS Inc. • Neogen Corporation *Other prominent players in the market which can be profiled as a part of customization: Zoetis, Inc. Virbac SA, HESKA Corporation Veterinary Molecular Diagnostics, Inc. For Sample Pages & Detailed Report Description Click @ https://www.gmiresearch.com/report/global-veterinary-molecular-diagnostic- market-opportunities-forecast-geography-instruments-consumables-technology- animal-type-livestock-share-insights.html Table of Contents (TOC) 1. Executive Summary 2. Introduction 2.1. Study Objectives 2.2. Market Definition 2.2.1. Market Covered 2.2.2. Geographical Coverage 2.2.3. Study Years & Currency

7. 2.3. Market Stakeholders 2.4. Key Questions this Study will Answer 2.5. GMI Research’s Approach & Methodology 3. Global Veterinary Molecular Diagnostic Market – Overview 3.1. Introduction ` 3.2. Market Segmentation 3.3. Value Chain Analysis 3.4. Drivers 3.5. Restraints 3.6. Trends 4. Global Veterinary Molecular Diagnostic Market Revenue Forecast till 2025 5. Global Veterinary Molecular Diagnostic Market by Product Type Revenue Forecast till 2025 5.1. Instruments 5.2. Consumables 5.2.1. Reagents 5.2.2. Kits 5.2.3. Others 6. Global Veterinary Molecular Diagnostic Market by Technology Revenue Forecast till 2025 6.1. PCR 6.2. INAAT 6.3. Microarrays 6.4. DNA Sequencing 7. Global Veterinary Molecular Diagnostic Market by Animal Type Revenue Forecast till 2025 7.1. Companion Animals 7.1.1. Dogs 7.1.2. Horses

8. 7.1.3. Cats 7.2. Livestock Animals 7.2.1. Pigs 7.2.2. Cattles 7.2.3. Poultry 7.2.4. Others 8. Global Veterinary Molecular Diagnostic Market by End User Revenue Forecast till 2025 8.1. Veterinary Hospitals 8.2. Clinical Laboratories 8.3. Research Institutes 9. Global Veterinary Molecular Diagnostic Market by Geography Revenue Forecast till 2025 9.1. North America Veterinary Molecular Diagnostic Market Revenue Forecast till 2025 9.1.1. North America Veterinary Molecular Diagnostic Market by Product Type (Option 1: 25% customization) 9.1.1.1. Instruments 9.1.1.2. Consumables 9.1.1.3. Injectable Devices 9.1.1.3.1. Reagents 9.1.1.3.2. Kits 9.1.1.3.3. Others 9.1.2. North America Veterinary Molecular Diagnostic Market by Technology 9.1.2.1. PCR 9.1.2.2. INAAT 9.1.2.3. Microarrays 9.1.2.4. DNA Sequencing 9.1.3. North America Veterinary Molecular Diagnostic Market by Animal Type

9. 9.1.3.1. Companion Animals 9.1.3.1.1. Dogs 9.1.3.1.2. Horses 9.1.3.1.3. Cats 9.1.3.2. Livestock Animals 9.1.3.2.1. Pigs 9.1.3.2.2. Cattles 9.1.3.2.3. Poultry 9.1.3.2.4. Others 9.1.4. North America Veterinary Molecular Diagnostic Market by End User 9.1.4.1. Veterinary Hospitals 9.1.4.2. Clinical Laboratories 9.1.4.3. Research Institutes 9.2. Europe Veterinary Molecular Diagnostic Market Revenue Forecast till 2025 9.2.1. Europe Veterinary Molecular Diagnostic Market by Product Type (Option 2: 25% customization) 9.2.1.1. Instruments 9.2.1.2. Consumables 9.2.1.3. Injectable Devices 9.2.1.3.1. Reagents 9.2.1.3.2. Kits 9.2.1.3.3. Others 9.2.2. Europe Veterinary Molecular Diagnostic Market by Technology 9.2.2.1. PCR 9.2.2.2. INAAT 9.2.2.3. Microarrays 9.2.2.4. DNA Sequencing 9.2.3. Europe Veterinary Molecular Diagnostic Market by Animal Type 9.2.3.1. Companion Animals

10. 9.2.3.1.1. Dogs 9.2.3.1.2. Horses 9.2.3.1.3. Cats 9.2.3.2. Livestock Animals 9.2.3.2.1. Pigs 9.2.3.2.2. Cattles 9.2.3.2.3. Poultry 9.2.3.2.4. Others 9.2.4. Europe Veterinary Molecular Diagnostic Market by End User 9.2.4.1. Veterinary Hospitals 9.2.4.2. Clinical Laboratories 9.2.4.3. Research Institutes 9.3. Asia-Pacific Veterinary Molecular Diagnostic Market Revenue Forecast till 2025 9.3.1. Asia-Pacific Veterinary Molecular Diagnostic Market by Product Type (Option 3: 25% customization) 9.3.1.1. Instruments 9.3.1.2. Consumables 9.3.1.3. Injectable Devices 9.3.1.3.1. Reagents 9.3.1.3.2. Kits 9.3.1.3.3. Others 9.3.2. Asia-Pacific Veterinary Molecular Diagnostic Market by Technology 9.3.2.1. PCR 9.3.2.2. INAAT 9.3.2.3. Microarrays 9.3.2.4. DNA Sequencing

11. 9.3.3. Asia-Pacific Veterinary Molecular Diagnostic Market by Animal Type 9.3.3.1. Companion Animals 9.3.3.1.1. Dogs 9.3.3.1.2. Horses 9.3.3.1.3. Cats 9.3.3.2. Livestock Animals 9.3.3.2.1. Pigs 9.3.3.2.2. Cattles 9.3.3.2.3. Poultry 9.3.3.2.4. Others 9.3.4. Asia-Pacific Veterinary Molecular Diagnostic Market by End User 9.3.4.1. Veterinary Hospitals 9.3.4.2. Clinical Laboratories Research Institutes 9.4. Rest of the World Veterinary Molecular Diagnostic Market Revenue Forecast till 2025 9.4.1. Rest of the World Veterinary Molecular Diagnostic Market by Product Type (Option 4: 25% customization) 9.4.1.1. Instruments 9.4.1.2. Consumables 9.4.1.3. Injectable Devices 9.4.1.3.1. Reagents 9.4.1.3.2. Kits 9.4.1.3.3. Others 9.4.2. Rest of the World Veterinary Molecular Diagnostic Market by Technology 9.4.2.1. PCR 9.4.2.2. INAAT

12. 9.4.2.3. Microarrays 9.4.2.4. DNA Sequencing 9.4.3. Rest of the World Veterinary Molecular Diagnostic Market by Animal Type 9.4.3.1. Companion Animals 9.4.3.1.1. Dogs 9.4.3.1.2. Horses 9.4.3.1.3. Cats 9.4.3.2. Livestock Animals 9.4.3.2.1. Pigs 9.4.3.2.2. Cattles 9.4.3.2.3. Poultry 9.4.3.2.4. Others 9.4.4. Rest of the World Veterinary Molecular Diagnostic Market by End User 9.4.4.1. Veterinary Hospitals 9.4.4.2. Clinical Laboratories 9.4.4.3. Research Institutes 10. Competitive Landscape 10.1. Competitive Landscape 10.2. Porter 5 Analysis 10.3. Major players and their key strategies 10.4. Company Share Analysis 11. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice) 11.1. Thermo Fisher Scientific Inc. 11.1.1. Company Overview 11.1.2. Financials 11.1.3. Recent Developments

13. 11.2. QIAGEN N.V. 11.2.1. Company Overview 11.2.2. Financials 11.2.3. Recent Developments 11.3. IDEXX Laboratories Inc. 11.3.1. Company Overview 11.3.2. Financials 11.3.3. Recent Developments 11.4. VCA Inc. 11.4.1. Company Overview 11.4.2. Financials 11.4.3. Recent Developments 11.5. Biomedica Medizinprodukte GmbH & Co. KG 11.5.1. Company Overview 11.5.2. Financials 11.5.3. Recent Developments 11.6. HealthGene Corporation 11.6.1. Company Overview 11.6.2. Financials 11.6.3. Recent Developments 11.7. Bioneer 11.7.1. Company Overview 11.7.2. Financials 11.7.3. Recent Developments 11.8. ABAXIS Inc. 11.8.1. Company Overview 11.8.2. Financials 11.8.3. Recent Developments 11.9. Neogen Corporation

14. 11.9.1. Company Overview 11.9.2. Financials 11.9.3. Recent Developments 11.10. Veterinary Molecular Diagnostics, Inc. 11.10.1. Company Overview 11.10.2. Financials 11.10.3. Recent Developments 12. About GMI Research Buy Report @ https://tinyurl.com/ybrbh62n Related Report : Global Smart Pill Market By Application Type (Capsule Endoscopy, Drug Delivery and Patient Monitoring), By Target Area (Esophagus, Stomach, Small Intestine, Large Intestine and Others), By Indication (Esophageal Diseases, Small Bowel Diseases, Colon Diseases and Others), By End-User (Hospital, Diagnostic laboratories, Ambulatory Surgical Center, Research Institutes and Others) and by Geography – Opportunities & Forecast, 2018-2025 About US GMI Research is a market research and consulting firm which provides research- based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth.

15. Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:https://www.gmiresearch.com/productservices/marketcompetitiveintelligenc e.html Our Company Profile Solution Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients. We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles: https://www.gmiresearch.com/productservices/companyprofiles.html Contact – Sarah Nash Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate, Dublin D18 Y3X2, Ireland U.S Office +1 860 881 2270 Europe Office +353 1 442 8820 Email: sales@gmiresearch.com